Milind M. Gore

1.9k total citations
44 papers, 1.3k citations indexed

About

Milind M. Gore is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Milind M. Gore has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 29 papers in Public Health, Environmental and Occupational Health and 15 papers in Epidemiology. Recurrent topics in Milind M. Gore's work include Mosquito-borne diseases and control (29 papers), Viral Infections and Vectors (19 papers) and Virology and Viral Diseases (11 papers). Milind M. Gore is often cited by papers focused on Mosquito-borne diseases and control (29 papers), Viral Infections and Vectors (19 papers) and Virology and Viral Diseases (11 papers). Milind M. Gore collaborates with scholars based in India, United States and Sweden. Milind M. Gore's co-authors include Nagendra R. Hegde, Hilary Koprowski, Gajanan Sapkal, Bernhard Dietzschold, William H. Wunner, Paolo Casali, Hildegund C.J. Ertl, L. Ötvös, Atanu Basu and Vijay P. Bondre and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Journal of Virology.

In The Last Decade

Milind M. Gore

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milind M. Gore India 17 707 668 461 339 209 44 1.3k
Douglas M. Molina United States 24 436 0.6× 593 0.9× 520 1.1× 298 0.9× 811 3.9× 36 1.8k
Ming Qiao Australia 19 423 0.6× 303 0.5× 554 1.2× 99 0.3× 160 0.8× 36 1.1k
Erin Mehlhop United States 16 1.1k 1.5× 1.2k 1.8× 275 0.6× 358 1.1× 199 1.0× 18 1.9k
Mary Kate Hart United States 25 1.4k 2.1× 414 0.6× 739 1.6× 188 0.6× 342 1.6× 40 2.1k
Carolyn M. Hannan United Kingdom 13 548 0.8× 450 0.7× 533 1.2× 394 1.2× 605 2.9× 18 1.8k
Lewis Markoff United States 28 1.4k 1.9× 1.8k 2.6× 571 1.2× 339 1.0× 394 1.9× 42 2.4k
Bindu Sukumaran United States 18 483 0.7× 559 0.8× 254 0.6× 111 0.3× 453 2.2× 22 1.5k
Karima Brahimi France 20 212 0.3× 1.1k 1.7× 308 0.7× 229 0.7× 534 2.6× 32 1.8k
Meleri Jones United Kingdom 14 441 0.6× 403 0.6× 492 1.1× 114 0.3× 104 0.5× 24 1.2k
Ulrike Wille-Reece United States 14 211 0.3× 250 0.4× 376 0.8× 264 0.8× 401 1.9× 18 1.6k

Countries citing papers authored by Milind M. Gore

Since Specialization
Citations

This map shows the geographic impact of Milind M. Gore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milind M. Gore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milind M. Gore more than expected).

Fields of papers citing papers by Milind M. Gore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milind M. Gore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milind M. Gore. The network helps show where Milind M. Gore may publish in the future.

Co-authorship network of co-authors of Milind M. Gore

This figure shows the co-authorship network connecting the top 25 collaborators of Milind M. Gore. A scholar is included among the top collaborators of Milind M. Gore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milind M. Gore. Milind M. Gore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gore, Milind M., et al.. (2023). De novo design of anti-variant COVID-19 vaccine. Biology Methods and Protocols. 8(1). bpad021–bpad021.
2.
Gore, Milind M.. (2020). Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour. Viral Immunology. 33(6). 423–433.
3.
Tandale, Babasaheb V., Siraj Ahmed Khan, K. P. Kushwaha, et al.. (2018). Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study. Journal of Infection and Public Health. 11(5). 713–719. 25 indexed citations
4.
Murhekar, Manoj, et al.. (2017). Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015. The Indian Journal of Medical Research. 145(1). 63–69. 11 indexed citations
5.
Gore, Milind M., et al.. (2016). A study of sequelae of acute encephalitis syndrome in district Gorakhpur, Uttar Pradesh, India. International Journal of Research in Medical Sciences. 1062–1067. 7 indexed citations
6.
Mitra, Monjori, Gadey Sampath, Balaji Krishnamurthy, et al.. (2015). A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains. The Journal of Infectious Diseases. 212(5). 715–725. 50 indexed citations
7.
Bhatt, Girish Chandra, et al.. (2015). Japanese Encephalitis Presenting Without Cerebrospinal Fluid Pleocytosis. The Pediatric Infectious Disease Journal. 34(12). 1416–1416. 1 indexed citations
9.
Sapkal, Gajanan, et al.. (2012). Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus. Virus Research. 166(1-2). 77–86. 8 indexed citations
10.
Sapkal, Gajanan, et al.. (2012). Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice. Virus Research. 170(1-2). 118–125. 8 indexed citations
11.
Patowary, Ashok, Rajendra Chauhan, Meghna Singh, et al.. (2012). De novo identification of viral pathogens from cell culture hologenomes. BMC Research Notes. 5(1). 11–11. 7 indexed citations
12.
Gore, Milind M., et al.. (2011). Comparative analysis of macrophage associated vectors for use in genetic vaccine. PubMed. 9(1). 10–10. 6 indexed citations
13.
Gangwar, Roopesh Singh, Pratip Shil, Gajanan Sapkal, Siraj Ahmed Khan, & Milind M. Gore. (2011). Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes. Virus Research. 163(1). 40–50. 13 indexed citations
14.
Biswas, Moanaro, et al.. (2009). Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model. Journal of General Virology. 90(4). 818–826. 23 indexed citations
15.
Biswas, Moanaro, Swagata Kar, Rupa Singh, et al.. (2009). Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice. Journal of Medical Virology. 82(2). 304–310. 34 indexed citations
16.
Sapkal, Gajanan, Vijay P. Bondre, Pooja Fulmali, et al.. (2009). Enteroviruses in Patients with Acute Encephalitis, Uttar Pradesh, India. Emerging infectious diseases. 15(2). 295–298. 94 indexed citations
17.
Dewasthaly, Shailesh, et al.. (2007). Chimeric T Helper-B Cell Peptides Induce Protective Response Against Japanese Encephalitis Virus in Mice. Protein and Peptide Letters. 14(6). 543–551. 8 indexed citations
18.
Dewasthaly, Shailesh, et al.. (2001). Monoclonal antibody raised against envelope glycoprotein peptide neutralizes Japanese encephalitis virus. Archives of Virology. 146(7). 1427–1435. 10 indexed citations
19.
Ötvös, L., B Dietzschold, M. Hollósi, et al.. (1992). Breakage in alpha-helix: a recognition site for anti-rabies virus ribonucleoprotein antibody.. PubMed. 2(2). 167–70. 3 indexed citations
20.
Goldfarb, Inna, Nagaradona Harindranath, Milind M. Gore, et al.. (1990). Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus.. The Journal of Experimental Medicine. 171(1). 19–34. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026